静脉性腿部溃疡压迫疗法的随机对照试验(VenUS 6):一项实用性、多中心、平行组、三臂随机对照试验的研究方案
VenUS 6是一项实用性、多中心、三臂平行组随机对照试验,受试者为患有静脉性腿部溃疡的成人患者,随机接受压迫绷带、双层绷带或循证压迫(双层弹力袜或四层绷带)。主要结局为随机化至愈合的时间(天)。试验旨在比较三种压迫疗法的临床与成本效益,于2021年1月开始招募,目前在30个中心招募。
要点
- 静脉性腿部溃疡推荐一线治疗为踝部提供40 mmHg压力的全(高)压迫疗法。
- VenUS 6比较压迫绷带、双层绷带与循证压迫(双层弹力袜或四层绷带)的愈合时间。
- 主要结局为随机化至愈合(无结痂的完全上皮覆盖)的天数。
核心结论
- VenUS 6将提供不同压迫疗法治疗静脉性腿部溃疡的临床与成本效益的可靠证据。
研究设计与样本
- 实用性、多中心、三臂、平行组随机对照试验,受试者为患有静脉性腿部溃疡的成人患者。
- 随机分为三组:压迫绷带、双层绷带或循证压迫(双层弹力袜或四层绷带)。
- 随访4至12个月,主要结局为随机化至愈合(无结痂的完全上皮覆盖)的天数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous leg ulcer(s) are common, recurring, open wounds on the lower leg, resulting from diseased or damaged leg veins impairing blood flow. Wound healing is the primary treatment aim for venous leg ulceration, alongside the management of pain, wound exudate and infection. Full (high) compression therapy delivering 40 mmHg of pressure at the ankle is the recommended first-line treatment for venous leg ulcers. There are several different forms of compression therapy available including wraps, two-layer hosiery, and two-layer or four-layer bandages. There is good evidence for the clinical and cost-effectiveness of four-layer bandage and two-layer hosiery but more limited evidence for other treatments (two-layer bandage and compression wraps). Robust evidence is required to compare clinical and cost-effectiveness of these and to investigate which is the best compression treatment for reducing time to healing of venous leg ulcers whilst offering value for money. VenUS 6 will therefore investigate the clinical and cost-effectiveness of evidence-based compression, two-layer bandage and compression wraps for time to healing of venous leg ulcers. METHODS: VenUS 6 is a pragmatic, multi-centre, three-arm, parallel-group, randomised controlled trial. Adult patients with a venous leg ulcer will be randomised to receive (1) compression wraps, (2) two-layer bandage or (3) evidence-based compression (two-layer hosiery or four-layer bandage). Participants will be followed up for between 4 and 12 months. The primary outcome will be time to healing (full epithelial cover in the absence of a scab) in days since randomisation. Secondary outcomes will include key clinical events (e.g. healing of the reference leg, ulcer recurrence, ulcer/skin deterioration, amputation, admission/discharge, surgery to close/remove incompetent superficial veins, infection or death), treatment changes, adherence and ease of use, ulcer related pain, health-related quality of life and resource use. DISCUSSION: VenUS 6 will provide robust evidence on the clinical and cost-effectiveness of the different forms of compression therapies for venous leg ulceration. VenUS 6 opened to recruitment in January 2021 and is currently recruiting across 30 participating centres. TRIAL REGISTRATION: ISRCTN67321719 . Prospectively registered on 14 September 2020.
引用
- Arundel CE, Welch C, Saramago P, et al. A randomised controlled trial of compression therapies for the treatment of venous leg ulcers (VenUS 6): study protocol for a pragmatic, multicentre, parallel-group, three-arm randomised controlled trial. Trials. 2023. PMID: 37237393. doi:10.1186/s13063-023-07349-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。